Select Medical Stock Fair Value – Barclays PLC Decreases Investment in Select Medical Holdings Co.
February 14, 2023
Trending News 🌥️
Select Medical Stock Fair Value – Select Medical ($NYSE:SEM) Holdings Co is a publicly traded healthcare company that specializes in providing specialized and complex medical treatments. The company operates through its network of long-term acute care hospital, inpatient rehabilitation, outpatient rehabilitation, and occupational health brands. Based in Mechanicsburg, Pennsylvania, Select Medical has become one of the largest providers of post-acute care services in the US. Recently, Barclays PLC has decreased its stake in Select Medical Holdings Co. Following the news, the company’s stock has been trading lower. Barclays PLC is a British multinational investment bank and financial services holding company based in London. This news comes amid a backdrop of increasing public scrutiny of healthcare companies that are involved in providing services to the public.
The move by Barclays PLC reflects its shift towards other investments that are better positioned to capitalize on current trends in the healthcare sector. It also serves as a reminder of the importance of diversifying one’s portfolio and selecting investments that are better suited to the current market situation and industry outlook. Select Medical Holdings Co has seen a decrease in Barclays PLC’s stake and its stock has been trading lower since news of the move was announced. Nevertheless, the company remains well-positioned for future growth as it continues to focus on providing specialized, innovative, and cost-effective care for its patients. With a strong base of loyal customers and a commitment to providing quality services, Select Medical Holdings Co should continue to be a viable investment option for those looking to diversify their portfolios in the healthcare sector.
Stock Price
On Thursday, Barclays PLC decreased its investment in Select Medical Holdings Co. (SELECT MEDICAL), a leading operator of specialty hospitals and outpatient rehabilitation clinics in the United States. The stock opened at $28.4 and closed at $28.2, reflecting an increase of 0.5% from its previous closing price of $28.1. The decision to reduce investment appears to have been driven by a belief that the company’s stock was overvalued. Many analysts share the sentiment that SELECT MEDICAL has been overbought and is likely to underperform in the near future. The company’s financial results for the past quarter were reported as being significantly worse than expected, with revenue falling short of estimates.
It is unsurprising that Barclays PLC has decided to reduce its investment in SELECT MEDICAL, given the current market conditions and the company’s overall performance. While the stock has performed relatively well in recent weeks, investors remain cautious about the company’s outlook and are looking for indications of growth in future quarters before investing further. This decision highlights the importance of careful assessment of investment opportunities in order to maximize returns and minimize risk. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Select Medical. More…
| Total Revenues | Net Income | Net Margin |
| 6.31k | 175.1 | 6.5% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Select Medical. More…
| Operations | Investing | Financing |
| 216.22 | -256.59 | -647.38 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Select Medical. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 7.55k | 6.19k | 8.7 |
Key Ratios Snapshot
Some of the financial key ratios for Select Medical are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 5.7% | -4.2% | 12.3% |
| FCF Margin | ROE | ROA |
| 0.3% | 24.6% | 3.5% |
Analysis – Select Medical Stock Fair Value
GoodWhale has conducted an analysis of SELECT MEDICAL‘s fundamentals to determine its intrinsic value. Using our proprietary Valuation Line, we found that the intrinsic value of one SELECT MEDICAL share is approximately $33.4. Currently, the stock is trading at $28.2, which is 15.7% lower than the intrinsic value. This means that the stock is undervalued, making it a good opportunity for investors who are looking for potentially profitable stocks. The company has a strong balance sheet, with low debt levels, and has been consistently profitable over the last few years. It also has a wide range of customers, giving it a broad base of revenue. This makes SELECT MEDICAL a stable company that could be a good investment for those looking to diversify their portfolios. Overall, GoodWhale’s analysis of SELECT MEDICAL’s fundamentals suggests that the company is undervalued and could offer investors a profitable opportunity. Investors should keep in mind that this is just one analysis and they should conduct their own due diligence before investing in the stock. More…
Peers
The company’s competitors include Eukedos SpA, Med Life SA, Athens Medical Centre SA, and other similar companies.
– Eukedos SpA ($LTS:0Q8E)
Eukedos SpA is a pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of rare diseases. The company has a market cap of 28.09M as of 2022 and a Return on Equity of 10.29%. Eukedos SpA is headquartered in Milan, Italy.
– Med Life SA ($LTS:0RO5)
MedLife SA is a publicly traded company with a market capitalization of 2B as of 2022. The company’s return on equity is 22.48%. MedLife SA is a leading provider of medical and healthcare services in South America. The company offers a full range of services including primary care, hospital care, specialty care, and behavioral health services. MedLife SA also has a strong presence in the insurance and managed care markets.
– Athens Medical Centre SA ($LTS:0ONM)
Athens Medical Centre SA is a medical company that operates in Greece. The company has a market cap of 117.53M as of 2022 and a return on equity of 18.02%. The company provides medical services and products to patients in Greece. Athens Medical Centre SA operates in the following segments: Medical Services, Medical Products, and Other. The Medical Services segment provides medical services to patients in Greece. The Medical Products segment provides medical products to patients in Greece. The Other segment includes activities such as real estate and investments.
Summary
Investors in Select Medical Holdings Co. have been impacted by the recent announcement that Barclays PLC has decreased their investment in the company. The decrease in investment could suggest that the health care provider is facing financial issues, making it a riskier investment for Barclays. Analysts are suggesting that investors should keep a close watch on the company’s stock performance and financials to gain a better understanding of how the decreased investment may affect operations and long-term outlook. While there is no clear indication of future performance, investors should remain cautious and consider their portfolio diversification strategies when determining how to allocate their resources.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
